Pay in 4 interest-free payments of $5.94 Learn more
Ships within 48 hours · Estimated delivery Aug 9 - Aug 14
Scot Roberts, PhD, Chief Scientific Officer Number Of Employees: ~57 Stage: Publicly traded Financial Snapshot: The companys market cap as of July 2026 was $548 million
Vigor Compounding supports providers offering compounded GLP-1 therapy options by working with trusted, licensed 503A compounding pharmacy partners
Choosing a weight loss medication with your healthcare provider can be challenging with so many options available
This protocol aligns with the 16-week Wegovy dose escalation schedule
The most appropriate option depends on factors such as weight loss goals, health history, and how an individual responds to treatment under medical supervision
It may also be considered for certain adults who are overweight and have weight-related health concerns
US$ 27.12
US$ 28.54
US$ 23.38
US$ 25.18
US$ 28.08
US$ 29.92
US$ 24.95
US$ 25.71
US$ 27.91
